Should I Buy ALLR Stock in 2026?
Data-driven analysis and honest assessment for Allarity Therapeutics Inc
Current Price: $1.05P/E: 0.2
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
Very low P/E of 0.2 suggests undervaluation
Growth data limited
Currently unprofitable
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$1.05
P/E Ratio
0.21
Revenue Growth
N/A
Profit Margin
N/A
Market Cap
$0.0B
Dividend Yield
None
How ALLR Compares to Competitors
Understanding how ALLR stacks up against peers helps inform your investment decision.
How ALLR Compares to Peers
Upcoming Events for ALLR
+5 Reasons TO Buy ALLR
1. Attractively valued at 0.2x earnings
strongA P/E ratio of 0.2 is below the market average of ~20x, suggesting the stock may be undervalued.
2. High gross margins of 510%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
-5 Reasons NOT to Buy ALLR
1. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
2. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
3. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy ALLR?
Investment Profile
Risk Level
Very High
Recommended Holding Period
3-5 years
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in ALLR, compare these Health Care peers:
Pro tip: Compare ALLR directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for ALLR
Frequently Asked Questions
What is ALLR stock price today?
ALLR (Allarity Therapeutics Inc) stock is trading at $1.05 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is ALLR stock going up or down today?
ALLR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ALLR stock now?
The decision to buy ALLR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ALLR a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ALLR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ALLR stock overvalued or undervalued?
ALLR currently trades at a P/E ratio of 0.21, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if ALLR is fairly priced.
What is ALLR's P/E ratio?
ALLR has a price-to-earnings (P/E) ratio of 0.21, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is ALLR's market cap?
ALLR (Allarity Therapeutics Inc) has a market capitalization of $0.02 billion, making it a small-cap stock.
What is ALLR's price to book ratio?
ALLR trades at a price-to-book (P/B) ratio of 1.34, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Allarity Therapeutics Inc
Full Stock Analysis
Complete ALLR overview with charts and data
Is ALLR Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how ALLR stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Allarity Therapeutics Inc
Complete ALLR Analysis
Compare ALLR With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.